DR. MIELE COSMED GROUP SPÓŁKA AKCYJNA financials
DR. MIELE COSMED GROUP SPÓŁKA AKCYJNA
Country: PL Reporting currency: PLN Latest annual report: 2023-12-31
LEI:
2594009CXYWKREHIBZ14 Financial statements
(PLN, as reported — unscaled; 105 line items across 2 annual periods)
| Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | PLN 444.5M | PLN 396.6M |
| Gross profit | PLN 33.2M | PLN 2.0M |
| Employee benefits expense | PLN 70.5M | PLN 59.2M |
| Raw materials & consumables used | PLN 259.0M | PLN 263.1M |
| Depreciation & amortisation | PLN 12.0M | PLN 11.3M |
| Operating profit (EBIT) | PLN 33.0M | PLN 1.3M |
| Finance costs | PLN 6.0M | PLN 3.8M |
| Profit before tax | PLN 27.2M | -PLN 2.1M |
| Income tax expense | PLN 5.0M | PLN 170.0K |
| Profit for the year | PLN 22.2M | -PLN 2.3M |
| — attributable to owners | PLN 22.2M | -PLN 2.3M |
| — attributable to NCI | PLN 0 | PLN 0 |
| Total comprehensive income | PLN 21.8M | -PLN 2.2M |
| Per share | ||
| Basic EPS | PLN 0.25 | PLN -0.03 |
| Diluted EPS | PLN 0.25 | PLN -0.03 |
| Free cash flow / share | PLN 0.25 | PLN -0.01 |
| Cash flow statement | ||
| Net cash from operating activities | PLN 31.3M | PLN 5.8M |
| Net cash from investing activities | -PLN 12.9M | PLN 602.0K |
| Purchase of PP&E (capex) | PLN 9.7M | PLN 6.6M |
| Net cash from financing activities | -PLN 13.4M | -PLN 8.3M |
| Dividends paid | — | PLN 2.6M |
| Proceeds from borrowings | PLN 1.5M | PLN 33.4M |
| Repayments of borrowings | PLN 6.5M | PLN 29.8M |
| Lease liability payments | PLN 3.5M | PLN 5.9M |
| Net change in cash | PLN 4.9M | -PLN 1.9M |
| Balance sheet | ||
| Total assets | PLN 382.4M | PLN 374.3M |
| Non-current assets | PLN 261.2M | PLN 259.8M |
| Property, plant & equipment | PLN 132.9M | PLN 136.1M |
| Intangible assets & goodwill | PLN 30.1M | PLN 30.1M |
| Current assets | PLN 121.2M | PLN 114.5M |
| Inventories | PLN 51.1M | PLN 53.6M |
| Cash & equivalents | PLN 14.3M | PLN 9.4M |
| Total equity | PLN 234.4M | PLN 212.6M |
| — attributable to owners | PLN 234.4M | PLN 212.6M |
| Non-controlling interests | PLN 0 | PLN 0 |
| Non-current liabilities | PLN 29.6M | PLN 22.7M |
| Long-term borrowings | PLN 7.5M | PLN 150.0K |
| Lease liabilities (non-current) | PLN 9.5M | PLN 10.4M |
| Current liabilities | PLN 118.5M | PLN 139.0M |
| Lease liabilities (current) | PLN 3.1M | PLN 3.1M |
| Trade & other payables | PLN 70.0M | PLN 77.5M |
| Deferred tax liabilities | PLN 10.6M | PLN 10.5M |
| Derived metrics | ||
| Free cash flow | PLN 21.6M | -PLN 753.0K |
| Operating margin | 7.4% | 0.3% |
| Net margin | 5.0% | -0.6% |
| Return on equity | 9.5% | -1.1% |
| Cash conversion ratio | 1.41× | -2.56× |
| Capex coverage | 3.23× | 0.89× |
| Other reported items | ||
| Adjusted Weighted Average Shares | 87.3M | 87.3M |
| Adjustments For Decrease Increase In Inventories | PLN 2.5M | -PLN 11.7M |
| Adjustments For Decrease Increase In Trade Account Receivable | -PLN 2.6M | -PLN 249.0K |
| Adjustments For Depreciation and Amortisation Expense | PLN 12.0M | PLN 11.3M |
| Adjustments For Finance Costs | PLN 4.4M | PLN 3.4M |
| Adjustments For Income Tax Expense | -PLN 3.9M | -PLN 1.1M |
| Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities | -PLN 487.0K | -PLN 487.0K |
| Adjustments For Increase Decrease In Trade Account Payable | -PLN 9.2M | PLN 6.8M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -PLN 158.0K | -PLN 439.0K |
| Adjustments For Provisions | PLN 1.0M | PLN 355.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | PLN 439.0K | PLN 0 |
| Cash Flows From Used In Decrease Increase In Restricted Cash and Cash Equivalents | PLN 100.0K | PLN 88.0K |
| Changes In Inventories of Finished Goods and Work In Progress | PLN 5.0K | -PLN 4.4M |
| Comprehensive Income Attributable To Noncontrolling Interests | PLN 0 | PLN 0 |
| Comprehensive Income Attributable To Owners of Parent | PLN 21.8M | -PLN 2.2M |
| Cost of Merchandise Sold | PLN 13.2M | PLN 12.5M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | PLN 39.9M | PLN 53.2M |
| Current Provisions For Employee Benefits | PLN 2.2M | PLN 1.7M |
| Current Tax Assets Current | PLN 0 | PLN 440.0K |
| Current Tax Liabilities Current | PLN 261.0K | PLN 0 |
| Deferred Income Other Than Contract Liabilities | PLN 3.1M | PLN 3.5M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | PLN 0 | PLN 2.6M |
| Equity and Liabilities | PLN 382.4M | PLN 374.3M |
| Expense By Nature | PLN 411.3M | PLN 394.5M |
| Finance Income | PLN 181.0K | PLN 404.0K |
| Increase Decrease In Cash and Cash Equivalents | PLN 4.9M | -PLN 1.9M |
| Increase Decrease Through Change In Equity of Subsidiaries | PLN 0 | PLN 0 |
| Increase Decrease Through Transfers and Other Changes Equity | PLN 0 | PLN 0 |
| Intangible Assets Other Than Goodwill | PLN 93.5M | PLN 93.7M |
| Interest Paid Classified As Financing Activities | PLN 4.5M | PLN 3.6M |
| Interest Received Classified As Investing Activities | PLN 111.0K | PLN 154.0K |
| Investment Property | PLN 4.7M | PLN 67.0K |
| Issued Capital | PLN 87.3M | PLN 87.3M |
| Liabilities | PLN 148.0M | PLN 161.7M |
| Miscellaneous Other Operating Expense | PLN 3.1M | PLN 3.0M |
| Miscellaneous Other Operating Income | PLN 2.9M | PLN 2.3M |
| Noncurrent Provisions For Employee Benefits | PLN 1.9M | PLN 1.5M |
| Other Adjustments For Noncash Items | -PLN 23.0K | -PLN 118.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -PLN 441.0K | PLN 43.0K |
| Other Expense By Nature | PLN 18.2M | PLN 14.5M |
| Other Inflows Outflows of Cash Classified As Financing Activities | -PLN 628.0K | PLN 0 |
| Other Inflows Outflows of Cash Classified As Investing Activities | -PLN 3.4M | PLN 0 |
| Payments To Acquire Or Redeem Entitys Shares | PLN 0 | PLN 31.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | PLN 216.0K | PLN 7.2M |
| Profit Loss From Continuing Operations | PLN 22.2M | -PLN 2.3M |
| Profit Loss From Discontinued Operations | PLN 0 | PLN 0 |
| Purchase of Treasury Shares | — | PLN 31.0K |
| Reserve of Exchange Differences On Translation | -PLN 1.0M | -PLN 708.0K |
| Retained Earnings Excluding Profit Loss For Reporting Period | -PLN 39.7M | -PLN 32.4M |
| Retained Earnings Profit Loss For Reporting Period | PLN 22.2M | -PLN 2.3M |
| Rightofuse Assets That Do Not Meet Definition of Investment Property | PLN 14.3M | PLN 15.2M |
| Services Expense | PLN 34.6M | PLN 35.2M |
| Statutory Reserve | PLN 77.0M | PLN 72.1M |
| Tax Expense Other Than Income Tax Expense | PLN 3.8M | PLN 3.0M |
| Trade Receivables | PLN 46.2M | PLN 42.5M |
| Treasury Shares | PLN 1.1M | PLN 1.1M |
| Weighted Average Shares | 87.3M | 87.3M |
Methodology
Every line item above is a fact tagged in DR. MIELE COSMED GROUP SPÓŁKA AKCYJNA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (PLN), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.